Background and purpose Myasthenia gravis (MG) patients could be a vulnerable group in
the pandemic era of coronavirus 2019 (COVID‐19) mainly due to respiratory muscle …

The current pandemic caused by the new severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has become a public health emergency. To date, March 1, 2021, coronavirus …

The use of autopsies in medicine has been declining. The COVID-19 pandemic has
documented and rejuvenated the importance of autopsies as a tool of modern medicine. In …

Abstract The coronavirus disease 2019 (COVID-19) pandemic is concerning for patients with
neuroimmunological diseases who are receiving immunotherapy. Uncertainty remains …

Type I Interferonopathy in Muscle in a Man with Covid-19 Generalized, predominantly
proximal weakness and a greatly elevated creatine kinase level developed in a man with …

The novel Coronavirus disease-19 (COVID-19) pandemic has posed several challenges for
neuromuscular disorder (NMD) patients. The risk of a severe course of SARS-CoV-2 …

Learning academic writing seems to be a great challenge for most English as a Foreign
Language (EFL) students in non-native English-speaking countries, including in Indonesia …

Background: The COVID-19 pandemic has within months turned the world upside down.
With personal distancing and shortage of personal protective equipment, face-to-face health …

Objective To describe the clinical characteristics and outcomes of coronavirus disease 2019
(COVID-19) among patients with myasthenia gravis (MG) and identify factors associated with …

Abstract Purpose of Review SARS-CoV-2 drove the catastrophic global phenomenon of the
COVID-19 pandemic resulting in a multitude of systemic health issues, including bone loss …